Immunomic Therapeutics, Inc.

Immunomic Therapeutics is a clinical stage biotech company applying proprietary vaccine technology to the $11 billion dollar allergy market.

  • Stage $1M in TTM Revenue
  • Industry Biotechnology
  • Location Hershey, PA, USA
  • Currency USD
  • Founded January 2006
  • Employees 5
  • Website immunomix.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free